| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/24/2013 | US20130025001 Sugar and Lipid Metabolism Regulators in Plants II |
| 01/24/2013 | US20130023647 Modified human thymic stromal lymphopoietin |
| 01/24/2013 | US20130023643 Nuclear localization signal peptides derived from vp2 protein of chicken anemia virus and uses of said peptides |
| 01/24/2013 | US20130023485 Parenteral formulations of peptides for the treatment of systematic lupus erythematosus |
| 01/24/2013 | US20130023480 Purified Bowman-Birk Protease Inhibitor Proteins Isolated from a Soy Processing Sttream |
| 01/24/2013 | US20130023478 Aquaretic and natriuretic polypeptides lacking vasodilatory activity |
| 01/24/2013 | US20130023477 Growth hormone fusion proteins |
| 01/24/2013 | US20130023476 Pharmaceutical Preparation Comprising Recombinant HCG |
| 01/24/2013 | US20130023474 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 01/24/2013 | US20130023473 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity |
| 01/24/2013 | US20130023470 Exendin and exendin agonists for eating disorders |
| 01/24/2013 | US20130023466 Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders |
| 01/24/2013 | US20130023464 Novel compounds and their effects on feeding behaviour |
| 01/24/2013 | US20130023461 Oligopeptide compounds and uses thereof |
| 01/24/2013 | US20130023426 Methods of Detecting Signatures of Disease or Conditions in Bodily Fluids |
| 01/24/2013 | US20130023032 Synergistic Attenuation of Vesicular Stomatitis Virus, Vectors Thereof and Immunogenic Compositions Thereof |
| 01/24/2013 | US20130023030 Recovery of recombinant human parainfluenza virus type 2 (hypiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 01/24/2013 | US20130023004 Fluorogenic substrate for adamts13 |
| 01/24/2013 | US20130022999 Protein fragment complementation assays for the detection of biological or drug interactions |
| 01/24/2013 | US20130022997 Monoclonal antibody against pbp2a derived from mrsa with dual binding activities |
| 01/24/2013 | US20130022983 Colon and Rectal Tumor Markers and Methods of Use Thereof |
| 01/24/2013 | US20130022968 Modular nucleotide compositions and uses therefor |
| 01/24/2013 | US20130022876 Surface modified polymeric materials, modified functionalized polymers, functional polymers, and methods |
| 01/24/2013 | US20130022707 Grain quality through altered expression of seed proteins |
| 01/24/2013 | US20130022669 Branched, compact polyethyleneglycol derivatives |
| 01/24/2013 | US20130022661 Bio-remodable bone augmentation device and method |
| 01/24/2013 | US20130022639 Expression of meningococcal fhbp polypeptides |
| 01/24/2013 | US20130022634 New composition and methods for treatment of autoimmune and allergic diseases |
| 01/24/2013 | US20130022633 MENINGOCOCCAL fHBP POLYPEPTIDES |
| 01/24/2013 | US20130022631 Vaccine for chikungunya virus infection |
| 01/24/2013 | US20130022630 Method for treating amyloid disease |
| 01/24/2013 | US20130022613 Wise/sost nucleic acid sequences and amino acid sequences |
| 01/24/2013 | US20130022608 FULL-LENGTH IgG IMMUNOGLOBULINS CAPABLE OF RECOGNIZING A HETEROSUBTYPE NEUTRALIZING EPITOPE ON THE HEMAGGLUTININ STEM REGION AND USES THEREOF |
| 01/24/2013 | US20130022607 Mucosal vascular addressins and uses thereof |
| 01/24/2013 | US20130022599 Method of treating fibroproliferative disorders |
| 01/24/2013 | US20130022590 Compositions Comprising Zinc Finger Domains and Uses Therefor |
| 01/24/2013 | US20130022578 Methods and system for interfering with viability of bacteria and related compounds and compositions |
| 01/24/2013 | US20130022571 Methods for treating viral infection using il-28 and il-29 cysteine mutants |
| 01/24/2013 | US20130022546 Peptides that Specifically Target Amyloid Deposits |
| 01/24/2013 | US20130022544 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 01/24/2013 | DE102006030566B4 Verfahren und Reagenzien zur Diagnose entzündlicher Lebererkrankungen Methods and reagents for diagnosis of inflammatory liver disease |
| 01/24/2013 | CA2842321A1 Engineered microbe-targeting molecules and uses thereof |
| 01/24/2013 | CA2842268A1 Biomarkers for ankylosing spondylitis |
| 01/24/2013 | CA2842068A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira |
| 01/24/2013 | CA2842067A1 Novel il-17r-ecd mutants |
| 01/24/2013 | CA2842055A1 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene |
| 01/24/2013 | CA2841994A1 Compositions and methods for immunomodulation |
| 01/24/2013 | CA2841710A1 Methods of transcription activator like effector assembly |
| 01/24/2013 | CA2841551A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/24/2013 | CA2840934A1 Plants resistant to insect pests |
| 01/24/2013 | CA2840925A1 Down-regulating gene expression in insect pests |
| 01/24/2013 | CA2840505A1 Plants having enhanced yield-related traits and a method for making the same |
| 01/23/2013 | EP2548959A1 Florigen-activating complex |
| 01/23/2013 | EP2548947A1 Transformant which produces glycine repeat protein |
| 01/23/2013 | EP2548893A2 Dual antagonist for tnf- and il-21 for preventing and treating autoimmune diseases |
| 01/23/2013 | EP2548888A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 01/23/2013 | EP2548887A1 Composition for inhibiting cancer metastasis containing dlk1-fc fusion protein as an active ingredient |
| 01/23/2013 | EP2548886A1 Genetic test for genetic disposition of haemophilia A in Havanese dogs |
| 01/23/2013 | EP2548885A2 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 01/23/2013 | EP2548884A2 Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| 01/23/2013 | EP2548882A1 Method for producing multiple recombinant disulfide bridged peptides |
| 01/23/2013 | EP2548573A1 Novel neutralizing immunogen (NIMIV) of Rhinovirus and its use for vaccine applications |
| 01/23/2013 | EP2548567A1 Polyoma virus JC peptides and proteins in vaccination and diagnostic applications |
| 01/23/2013 | EP2548025A2 Using phage epitopes to profile the immune response |
| 01/23/2013 | EP2548017A2 Small molecule inhibitors of muc1 and methods of identifying the same |
| 01/23/2013 | EP2547810A1 Method for production of polymer containing fibres |
| 01/23/2013 | EP2547775A1 Plants having enhanced yield-related traits and method for making the same |
| 01/23/2013 | EP2547772A1 Method for modifying the blooming date of a plant |
| 01/23/2013 | EP2547771A1 Production of proteins and polypeptides |
| 01/23/2013 | EP2547770A2 Live attenuated chimeric porcine circovirus vaccine |
| 01/23/2013 | EP2547699A1 Method for obtaining biologically active recombinant human g-csf |
| 01/23/2013 | EP2547697A1 Immune therapy |
| 01/23/2013 | EP2547696A2 Fragments of the pa subunit of rna dependent rna polymerase from pandemic influenza virus a 2009 h1n1, and their use |
| 01/23/2013 | EP2547695A1 Tumor vaccination involving a humoral immune response against self-proteins |
| 01/23/2013 | EP2547694A2 Novel signal peptide, and use thereof for producing recombinant proteins |
| 01/23/2013 | EP2547692A2 Peptide derivatives, preparation thereof and uses thereof as vectors |
| 01/23/2013 | EP2547364A1 Peptides, conjugates and method for increasing immunogenicity of a vaccine |
| 01/23/2013 | EP2547361A1 Bacterial vaccine components from staphylococcus aureus and uses thereof |
| 01/23/2013 | EP2547357A1 Adjuvanted vaccines for serogroup b meningococcus |
| 01/23/2013 | EP2547355A2 Tfpi inhibitors and methods of use |
| 01/23/2013 | EP2547337A1 Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals |
| 01/23/2013 | EP2261375B1 Method of preventing virus:cell fusion by inhibiting the function of the fusion initiation region in RNA viruses having class I membrane fusogenic envelope proteins |
| 01/23/2013 | CN1972958B Method of using adenoviral vectors to induce an immune response |
| 01/23/2013 | CN102893146A Hydrophobic interaction chromatography method |
| 01/23/2013 | CN102892886A Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use |
| 01/23/2013 | CN102892879A Method and composition for inducing human pluripotent stem cells |
| 01/23/2013 | CN102892786A Pd-1抗体 Pd-1 antibody |
| 01/23/2013 | CN102892781A Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
| 01/23/2013 | CN102892780A Method for obtaining biologically active recombinant human g-csf |
| 01/23/2013 | CN102892779A Neuregulin antagonists and use thereof in treating cancer |
| 01/23/2013 | CN102892778A A polynucleotide for use in treatment of influenza a virus induced diseases, encoding modified mx protein, said modified mx protein, and a transgenic animal expressing gene encoding modified mx protein |
| 01/23/2013 | CN102892431A Peptides, conjugates and method for increasing immunogenicity of a vaccine |
| 01/23/2013 | CN102892428A Parapoxvirus expressing the vp60 major capsid protein of the rabbit haemorrhagic disease virus |
| 01/23/2013 | CN102892284A Maize event dp-004114-3 and methods for detection thereof |
| 01/23/2013 | CN102888413A Hcv基因 Hcv gene |
| 01/23/2013 | CN102888411A Eucalyptus PGEF13 gene and plant expression vector, host cell and applications thereof |
| 01/23/2013 | CN102888410A Eucalyptus PGEF17 gene, and plant expression vector, host cell and application thereof |
| 01/23/2013 | CN102888408A Application of paddy rice RAD51C gene in fertility control |
| 01/23/2013 | CN102888406A Human idiopathic basal ganglia calcification disease-causing gene and coding protein thereof |
| 01/23/2013 | CN102887953A Anti-abeta antibodies and their use |